Test Price
2,800 AED✅ Home Collection Available
BICC1 Gene Renal Cystic Dysplasia Susceptibility Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين BICC1 للقابلية للإصابة بخلل التنسج الكلوي الكيسي في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 15189 & ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy (8 AM – 11 PM).
- Clinical Guidance: Complimentary Telephonic Post-Test Clinical Guidance in result interpretation by a DHA-licensed genetic specialist.
- Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
يقدم هذا الاختبار الجيني المتطور تحليلًا دقيقًا لجين BICC1 لتقييم القابلية للإصابة بخلل التنسج الكلوي الكيسي، مع الالتزام بأعلى معايير هيئة الصحة بدبي وضمان الخصوصية وفقًا لقانون حماية البيانات الشخصية الإماراتي.
Overview
The BICC1 gene test screens for pathogenic variants linked to renal cystic dysplasia susceptibility using high-fidelity Next-Generation Sequencing (NGS). This predictive, non-invasive assay is essential for asymptomatic at-risk individuals, couples planning pregnancy, and patients with family history of hereditary renal-hepatic disorders. يُستخدم الاختبار لتحديد الطفرات الجينية في جين BICC1 المرتبطة بخلل التنسج الكلوي الكيسي.
| Feature | Our Test (UAE – DNA Labs) | Closest Alternative (Overseas Lab) |
|---|---|---|
| Precision | >99.9% analytical sensitivity & specificity (NGS with full gene coverage) | Variable (may miss deep intronic variants) |
| Methodology | Next-Generation Sequencing (NGS) with Sanger confirmation – fully aligned with DHA/MOHAP standards | Microarray or targeted genotyping (limited) |
| Speed | 3–4 Weeks (local processing, cold-chain secure) | 4–8 Weeks (international shipping + customs) |
Physician Insight & Safety Protocol
"As a DHA-licensed nephrologist, I must emphasize that a genetic predisposition does not equal a clinical diagnosis; this test must always be interpreted in the context of renal ultrasound, family history, and biochemical markers. Patients should not make autonomous treatment decisions based solely on this report, and comprehensive genetic counselling is mandatory before and after testing." – Dr. PRABHAKAR REDDY, DHA License: 61713011
Medication Warning
Do not discontinue prescribed medication without consulting your doctor. If you are on antihypertensives, diuretics, or immunosuppressants, abrupt cessation could destabilize renal function. Always discuss test motivation with your treating physician.
Safety Exclusion Criteria & ER Red Flags
- Exclusion: Active systemic infection (fever >38.5°C), inability to provide informed consent, or current hospitalization for acute renal injury.
- Do NOT proceed with home collection if: You experience sudden flank pain, hematuria, or rapidly declining urine output – seek immediate emergency care.
- Minor (<18 years): Requires both parents’ consent and a paediatric nephrologist referral, as per UAE CDS Law 2026 (Minors Genetic Testing Provisions).
Patient FAQ & Clinical Guidance
1. What does the BICC1 gene renal cystic dysplasia susceptibility test detect?
This NGS-based assay identifies pathogenic variants in the BICC1 gene that are conclusively linked to autosomal recessive renal cystic dysplasia and related hepatorenal fibrocystic diseases, providing a definitive molecular diagnosis for at-risk individuals.
يكشف هذا الاختبار عن الطفرات المسببة للأمراض في جين BICC1 المرتبطة بخلل التنسج الكلوي الكيسي المتنحي الجسدي، مما يوفر تشخيصًا جزيئيًا قاطعًا للأفراد المعرضين للخطر.
2. How is the sample collected and what is the turnaround time?
A certified phlebotomist collects 2–4 ml of whole blood in an EDTA tube during a home visit (8 AM–11 PM) under cold-chain ISO protocols, and you receive a detailed report within 3 to 4 weeks, including Sanger-validated variant interpretation.
يتم جمع عينة دم وريدي بواسطة أخصائي سحب دم معتمد خلال زيارة منزلية وفق معايير سلسلة التبريد، وتصدر النتائج الكاملة في غضون 3 إلى 4 أسابيع.
3. Is this covered by UAE medical insurance?
Many UAE insurers now reimburse medically indicated genetic testing when pre-authorized through a nephrologist or clinical geneticist; send your policy details via WhatsApp to +971 54 548 8731 for instant verification and direct billing assistance.
تغطي العديد من شركات التأمين في الإمارات هذا النوع من الفحوصات الجينية عند الحصول على موافقة مسبقة من طبيب متخصص، ويمكنك إرسال تفاصيل وثيقتك عبر الواتساب للتحقق الفوري.
DHA Facility License: 9834453 | Hotline: +971 54 548 8731
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians